[XENE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 30.14%
YoY- -74.42%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 536 8,766 3,737 8,124 2,218 4,358 5,150 -77.96%
PBT -31,198 -20,064 -25,080 -15,650 -22,326 -15,832 -12,337 85.92%
Tax -40 -394 484 -205 -217 -68 -14 101.73%
NP -31,158 -19,670 -25,564 -15,445 -22,109 -15,764 -12,323 85.91%
Tax Rate - - - - - - - -
Total Cost 31,694 28,436 29,301 23,569 24,327 20,122 17,473 48.89%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -5,813.06 -224.39 -684.08 -190.12 -996.80 -361.73 -239.28 743.72%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.55 -0.37 -0.62 -0.37 -0.53 -0.43 -0.35 35.27%
EPS Diluted -0.55 -0.36 -0.62 -0.37 -0.53 -0.43 -0.33 40.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.